Resistance Mechanisms to Cyclin-Dependent Kinase Inhibitors
Year: 2018
Type: book-chapter
Author: Wolf Ruprecht Wiedemeyer
Institution: Cedars-Sinai Medical Center
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: cyclin-dependent kinase inhibitors, CDK4/6 inhibitors, acquired drug resistance, palbociclib, ribociclib, abemaciclib, dinaciclib, hormone receptor-positive breast cancer, estrogen receptor-positive breast cancer, MAPK signaling, PI3K signaling, RB1 mutation, cell cycle dysregulation, combination therapy
Open Access status: closed
OpenAlex ID: W2795296107
